Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
NSF is the FDA product code for Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment, a class II device type, regulated under 21 CFR 866.6030. FDA's definition for this code reads: "In vitro diagnostic test intended as a risk assessment test for the development of hepatocellular carcinoma (hcc) in patients with chronic liver diseases (cld). Elevated afpl3% values (= 10%) have been shown to be associated with a nine-fold increase in the risk of developing hcc in the next 6-12 months. Patients with...". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- NSF
- Device name
- Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
- FDA definition
- In vitro diagnostic test intended as a risk assessment test for the development of hepatocellular carcinoma (hcc) in patients with chronic liver diseases (cld). Elevated afpl3% values (= 10%) have been shown to be associated with a nine-fold increase in the risk of developing hcc in the next 6-12 months. Patients with elevated serum afpl3% should be more intensely evaluated for evidence of hcc according to the existing hcc practice guidelines in oncology.
- Regulation
- 21 CFR 866.6030
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 1
Clearances, product code NSF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
Applicants with the most clearances
Product code NSF| Applicant | Clearances |
|---|---|
| FUJIFILM Healthcare Americas Corporation | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Diagnostic Automation/ Cortez Diagnostics Inc.
- FUJIFILM Healthcare Americas Corporation
- FUJIFILM Healthcare Manufacturing Corporation MIE Office
- FUJIFILM Healthcare Manufacturing Corporation Minamiashigara Takematsu Office
- FUJIFILM Wako Pure Chemical Corporation Diagnostics Design Office (Amagasaki)
- Immunocentrix Corporation
- Monobind, Inc.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
